British Journal of Pharmacology 1993-05-01

Adenosine A3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat.

J R Fozard, A M Carruthers

Index: Br. J. Pharmacol. 109 , 3-5, (1993)

Full Text: HTML

Abstract

The cardiovascular effects of N6-2-(4-aminophenyl)ethyladenosine (APNEA), which when radiolabelled with 125I shows high affinity for the newly described adenosine A3 receptor, have been investigated in the angiotensin II-supported circulation of the pithed rat. APNEA induces hypotensive responses which are unaffected by high doses (20-40 mg kg-1) of the broad spectrum, adenosine receptor antagonist, 8-(p-sulphophenyl)theophylline (8-SPT). 8-SPT-resistant falls in blood pressure are also seen, in the absence of bradycardia, with 5'-N-ethylcarboxamidoadenosine (NECA) and the R- and S-enantiomers of N6-phenylisopropyladenosine (PIA). Xanthine insensitivity, high potencies of APNEA, NECA and R-PIA, and an enantiomeric selectivity favouring R- over S-PIA are distinguishing features of the adenosine A3 receptor. We suggest that hypotension in the pithed rat may be a functional correlate of this site.

Related Compounds

Structure Name/CAS No. Articles
N6-[2-(4-Aminophenyl)ethyl]adenosine Structure N6-[2-(4-Aminophenyl)ethyl]adenosine
CAS:89705-21-5